HYAL2 and benign neoplasm: An increase of HYAL2 expression occurred in benign tumors compared to normal ovaries (+76%, P = 0.037), and while a decrease was noted in grade 3 cancers compared to benign tumors (P = 0.0156) (Fig. 2C).